, on behalf of the French Vasculitis Study Group Abstract Objectives. Specific cardiac involvement in granulomatosis with polyangiitis (GPA) is probably underestimated since many of these conditions are subclinical. The objective of this study was to assess the prevalence and patterns of cardiac abnormalities detected by cardiac MRI (CMRI) in patients with GPA.
Introduction
Granulomatosis with polyangiitis (GPA) is an ANCA-associated small-vessel vasculitis of unknown aetiology [1, 2] that is characterized by ENT, lung and kidney involvement [3] . Cardiac signs are generally considered rare in GPA patients, but they may be life threatening [4] . Specific cardiac involvement in GPA is probably underestimated since many of these conditions are subclinical. A systematic echocardiography study [5] revealed abnormalities in 86% of GPA patients, 36% of which were considered to be related to GPA. We have proposed the use of contrastenhanced cardiac MRI (CMRI) as a sensitive tool for detecting and analysing cardiac involvement in ANCA-associated vasculitis (AAV) [6, 7] . We have also suggested that CMRI may be more sensitive than transthoracic echocardiography for evaluating GPA-related cardiac involvement in a small subgroup of patients [8] . CMRI also appears to be a reliable tool for monitoring treatment efficacy [79] . In this study we analysed the frequency and characteristics of cardiac involvement detected by CMRI in a large group of consecutive GPA patients.
Methods

Patients
Between June 2005 and July 2013, 31 consecutive, unselected GPA patients followed up at the French Reference Centre for Necrotizing Vasculitis were enrolled in this cross-sectional study. All GPA patients underwent CMRI at the Radiology Department of Cochin Hospital, Paris. GPA patients were recruited independent of disease activity (active or in remission), the presence or absence of cardiac signs and treatment regimen. All GPA patients fulfilled the ACR classification criteria [10] and/ or the revised Chapel Hill Consensus Conference definition classification for GPA [11] . This survey was conducted in compliance with the protocol of Good Clinical Practices and Declaration of Helsinki principles. The data analysed were collected as part of routine clinical care and this study conforms to standards currently applied in France, according to which cross-sectional studies are exempt from ethics approval and patient consent.
The following data were retrospectively collected for all patients from the French Vasculitis Study Group database and/or chart review: sex, age, cardiovascular risk factors, GPA duration, clinical signs and ANCA status (IF and ELISA), history of cardiovascular signs and cardiovascular symptoms at the time of CMRI. We also collected data for creatinine, CRP, cardiac troponin I and N-terminal probrain natriuretic peptide (NT-proBNP) concentrations. When available, ECG and echocardiography results performed within 2 months were analysed. Impaired left ventricular ejection fraction (LVEF) was defined as LVEF <45% on CMRI. Patients with clinical signs consistent with coronary artery disease alone underwent coronary angiography, as GPA preferentially affects small vessels and the main coronary arteries are usually unaffected. Pregnant women were not included.
Cardiac involvement was considered to be present if at least one of the following criteria was satisfied: the patient had current or previous clinical cardiac manifestation; or the echocardiogram provided evidence of heart enlargement, abnormal cardiac systolic function, abnormal cardiac diastolic function (mitral flow, E-wave and A-wave velocities, E/A ratio) [12] , motion abnormality, valvular abnormality or pericardial effusion; or ECG revealed complete right or left bundle-branch block, bifascicular block, atrioventricular block, supraventricular arrhythmia, ventricular tachycardia or pathological Q or ST abnormalities; or the blood cardiac troponin I or NT-proBNP concentration was elevated.
CMRI protocol
We used a 1.5 T CMRI system (Avanto, Siemens Medical, Erlangen, Germany) with a dedicated 32 channel cardiac coil. All patients were screened for the presence of contraindications for CMRI. All sequences were coupled to ECG monitoring, with the aim of obtaining an optimal signal (maximal R wave). All images were acquired during forced inspiration (except for free-breathing perfusion sequences) [13] .
Screening sequences in the gradient echo mode during apnoea were acquired in the axial plane and along the vertical long axis, short axis and horizontal long axis or four chamber view. The morphological sequences were obtained by black blood fast spin echo T2-weighted images with an echo time of at least 60 msec (fast spinecho with fat suppression by triple inversion) along the short axis (for oedema detection). Cine MRI was acquired in balanced steady-state free precession along the short axis, from the left ventricular apex to the valvular plane, for ventricular function. Four-cavities and long-axis balanced steady-state free precession sequences were also obtained. First-pass perfusion echo gradient sequences with echo planar readout in the short axis were acquired rapidly over a 45 sec period in free breathing following gadolinium chelate injection [0.2 mmol/kg of gadoterate meglumine (Dotarem, Guerbet, Aulnay-sous-bois, France)]. We then obtained early and delayed enhanced acquisitions at 1 and 10 min after injection, respectively, via inversion recovery T1-weighted sequences after recovery time optimization with a scouting sequence for the short, vertical and horizontal long axes.
MRI analysis
Two expert radiologists (H.G. and O.V.) who were blinded to all other information, including the clinical signs, ECG or echocardiography findings, independently assessed all CMR images. In cases of discrepancy, a consensus was reached by discussion (it was necessary for two patients).
LVEF, end-diastolic and end-systolic volumes were measured from cine MR images on short axis planes by defining the endocardial borders at the end of systole and diastole with cardiac software (ARGUS, Siemens Medical). Segmental myocardial contractility was visually assessed from the cine sequences in three planes (short axis, long axis and four-chamber views).
Pericarditis was defined on the morphologic sequences by the presence or absence of pericardial effusion plus pericardial thickening. On T2-weighted suppression by triple inversion images, we analysed the presence or absence of a myocardial hypersignal by qualitative means and by topographic characterization. T2 signal intensity (SI) of the myocardium was evaluated compared with the SI of the skeletal muscles as normal, focal hyperintensity (>10 pixels >2 S.D. in two different planes) or global hyperintensity (myocardium SI/skeletal muscle SI >1.9). On perfusion sequences we visually analysed myocardial enhancement and looked for a perfusion defect. On early and delayed enhanced sequences we analysed the presence of abnormal enhancement, including its localization (number of segments involved, according to the American Heart Association classification [14] ) and its location relative to the myocardium (subendocardial, intramyocardial, subepicardial and transmural) [13] .
Statistical analysis
Categorical data are presented as numbers or percentages and continuous data are presented as the mean (S.D.) or median with interquartile range (IQR), as appropriate. For the patients with CMRI abnormalities, symptomatic patients were compared with asymptomatic patients. The number of segments involved, mean myocardial delayedenhancement score and LVEF were analysed for each group with a non-parametric test (Wilcoxon test or Fisher's exact test, as appropriate). We used Pearson's correlation test to assess the correlation between numerical parameters. We also analysed a subgroup of patients who had both echocardiography and CMRI data available. A comparison of the reliability of measurements from the two radiologists was performed with an intraclass correlation coefficient calculation. P-values <0.05 were considered statistically significant. Statistical analyses were performed with SAS 9.3 software (SAS Institute, Cary, NC, USA).
Results
Clinical characteristics
We included 31 GPA patients undergoing CMRI at some point in the course of their disease; 20 had active GPA (9 new onset, 11 relapses) and 11 were in remission at enrolment into the study. The clinical characteristics of the 11 women and 20 men enrolled in this study are presented in Table 1 . The mean age of patients was 49.5 years (S.D. 17.8; range 1682) and the mean GPA duration at the time of CMRI was 37.4 months (S.D. 49.0). Thirteen (42%) patients presented with cardiovascular risk factors and four had a history of GPA-associated cardiac signs. Ten patients had GPA-associated cardiac signs, including three with chest pain, three left-sided heart failure, two dyspnoea, two atrial fibrillation, one acute angina pectoris, one pericarditis and one palpitations ( Table 2) .
Three patients without clinical symptoms had an abnormal ECG. Two patients without clinical symptoms and with a normal ECG had abnormal echocardiograms. Coronary angiography was performed in five patients for suspicion of a coronary artery anomaly, including three who were normal, one with minimal coronary infiltration and one with a positive methylergometrine test.
We identified elevated NT-proBNP levels in 9 of 22 patients. Two were symptomatic. Six patients had abnormal cardiac troponin I concentrations, including three who were asymptomatic, one with acute left cardiac insufficiency, one with recent atrial fibrillation, one with acute angina pectoris and two with ECG abnormalities.
Pattern and distribution of CMRI abnormalities CMRI showed at least one abnormality in 19 of the 31 patients (61%). The presence of cardiovascular risk factors was not predictive of CMRI abnormality (7/19 vs 6/12 patients; P > 0.05). The main CMRI abnormalities are shown in Table 3 . The estimated reliability between therapists was 0.93 (95% CI 0.86, 0.97).
Morphological study
We found no increase in the SI on T2-weighted sequences.
Perfusion analysis
Perfusion defects at rest were detected visually on firstpass sequences for two patients. The first had symptoms (dyspnoea) and a history of myocarditis with a previous LVEF of 30%. His CMRI revealed the presence of multiple subendocardial and centromyocardial perfusion defects. The second patient was asymptomatic and his CMRI showed centromyocardial perfusion defects in the anterior, anteroseptal and inferoapical segments. LV kinetic abnormalities were found in 11 patients (37%), mostly in the form of diffuse or segmental LV hypokinesia. These abnormalities predominantly affected the mid-anterior segment.
Myocardial early gadolinium enhancement (EGE)
Myocardial EGE was detected in the myocardium in 5 of 31 (16%) patients and 3 were symptomatic. Myocardial EGE was associated in each of these cases with myocardial late gadolinium enhancement (LGE) in the same territory. The number of cardiovascular risk factors in patients with myocardial EGE on CMRI was no greater than in patients without CMRI abnormalities (2/5 vs 11/ 26 patients; P > 0.05). All had high enhancement scores.
Myocardial LGE
LGE was detected in 10 of 31 (32%) patients and 6 of these had cardiac signs (Figs 1 and 2 ). The number of cardiovascular risk factors in patients with myocardial delayed contrast enhancement on CMRI was no greater than in patients without CMRI abnormalities (3/9 vs 10/22 patients; P > 0.05).
LGE was mostly nodular (n = 9/10) and subepicardial (n = 5/10 LGE: 20 vs 60%, P = 0.07; LV hypokinesia: 10 vs 70%, P = 0.006]. The age, sex and cardiovascular risk factors were similar for these two groups.
Overall, 73% of the patients with cardiac signs had CMRI abnormalities. A comparison of the CMRI findings between patients with and without cardiac signs revealed that these two groups only differed in terms of the frequency of LGE (55 vs 20%; P = 0.04). We found no correlation between the ANCA PR3 status, CRP or creatininemia concentration and CMR abnormalities (r = 0.09, P = 0.63; r = À0.06, P = 0.74; r = 0.04, P = 0.81).
Outcome
We followed up 25 of 31 patients for >12 months [median follow-up 37 months (IQR 3146)] (Fig. 3) . Three patients died; one died from sepsis and the deaths in the remaining two cases were unrelated to GPA. Six (24%) patients experienced a relapse [median follow-up 50 months (IQR 3387)] as follows: three ENT relapses, two pulmonary relapses and one glomerulonephritis. None of these patients presented specifically with a cardiac relapse of GPA. The percentages of patients with a history of GPA-related cardiac signs, GPA-related cardiac signs at baseline or both, or patients with CMRI abnormalities who experienced a relapse were 2/6 (33%), 4/6 (67%), 4/6 (67%) and 5/6 (83%), respectively. The relapse rates for GPA patients with CMRI abnormalities and cardiac signs and for asymptomatic patients with CMRI abnormalities were 50% and 33%, respectively.
New CMR images were obtained for 11 patients who had CMRI abnormalities at baseline. The median time between two CMR scans was 12 months (IQR 616).
The results of the second CMR scan were normal for four patients. All of these were active at baseline and received a CYC pulse for treatment induction leading to remission.
A decrease in the size of the myocardial nodules was observed in two patients. Both had active GPA at baseline and achieved remission (after MTX for one and rituximab for the other).
The images remained unchanged for three patients, only one of whom had active GPA. He was treated with MTX and achieved remission. One patient still had active myocardial lesions and pericarditis on CMRI 16 months after his relapse, even though he underwent induction treatment with CYC.
A progression of CMRI abnormalities was seen in one patient, 4 months after the first CMRI. This check-up scan was probably carried out too early. This patient has since achieved remission on CYC treatment and has experienced no further relapse.
Discussion
The principal findings of this study are as follows. First, most (61%) of the patients with GPA had at least one abnormality on CMRI, which was more sensitive than echocardiography (31%) [5] . Second, CMRI made it possible to precisely analyse the different patterns of heart involvement in GPA by differentiating between morphological, functional, perfusion and early and delayed contrast enhancement abnormalities. Third, we found that longer disease duration (>18 months) was associated with hypokinesia in a larger number of cardiac segments or with early or delayed contrast enhancement. Fourth, patients presenting with new-onset GPA had fewer CMRI abnormalities than relapsing patients.
The high frequency of heart abnormalities observed on CMRI is consistent with necropsy studies, which have shown that $4060% of patients with GPA have histological lesions that are indicative of heart involvement [15, 16] . As in previous studies [1618] , this complication was rarely detectable at the patient's bedside. These results suggest that such alterations are underestimated on clinical examination and that CMRI is highly sensitive for their detection. However, the clinical significance of CMRI abnormalities has yet to be established.
Symptomatic patients seemed to have more extensive CMRI lesions. However, cardiac symptoms may occur when a sufficiently large part of the myocardium has been affected by vasculitis, causing a marked decrease in the LVEF. GPA can cause myocardial inflammation and fibrosis, both of which have already been visualized by CMRI in AAV [6, 8, 19] . LGE alone may not always distinguish between active disease and damage. LGE has been correlated with histologically proven fibrosis and active myocarditis [20] . In our study, 5 of 10 LGE abnormalities detected on CMRI were associated with EGE in the same myocardial segments. EGE and LGE were consistent with the expected distribution of myocardial inflammation [2023] . These lesions were mostly nodular, which is consistent with previous reports of granulomatous lesions of the myocardium [8, 15] . However, in the absence of endomyocardial biopsies, we cannot claim that these abnormalities correspond to areas of active granulomatous myocardial inflammation. Two patients had subendocardial LGE associated with perfusion defects and normal coronary angiograms; these lesions might be consistent with ischaemic lesions due to microvasculitis [6, 24] .
We found that CMRI was more sensitive and provided more information than echocardiography. Despite having a normal LVEF, most patients with GPA had systolic abnormalities on CMRI. This may reflect subclinical involvement of the myocardium, which is underdetected by standard echocardiography. CMRI should be used to improve cardiac evaluation or follow-up monitoring in GPA patients.
We found that patients with a longer disease duration had more kinetic and LGE abnormalities. These results suggest a progression of myocardial involvement over time in GPA [5, 9, 2527] . Previous studies have reported a broad spectrum and varying prevalence of cardiac abnormalities in GPA, which have been linked to disease activity or prognosis [2831] . We found that 19.0% of the asymptomatic GPA patients had LGE. Recent data in coronary ischaemic disease have shown that patients with LGE >5% are at a higher risk of future cardiac events than those without LGE or with LGE <5% [3234]. CMRI abnormalities in asymptomatic GPA patients may have an important impact on prognosis and mortality. Indeed, GPA-associated mortality rates were high in the past, and the relapse rate was 50% at 5 years. With improvements in immunosuppressant therapy (CYC and rituximab), the major concern in GPA patients is currently cardiovascular disease due to inflammation, drugs (corticosteroids) or accelerated atherosclerosis, and CMRI may provide a prognostic tool with LGE >5%. Early diagnosis is important for prompt therapy.
Our study has several limitations. We excluded patients with a very low creatinine clearance value, which is a contraindication for CMRI, thus our results may not be applicable to all GPA patients. The recommended CMRI criteria for the identification of myocardial inflammation are based on studies of suspected acute or chronic viral myocarditis [35] and have not yet been validated for autoimmune processes. We also did not perform T1 mapping sequences, which could add important information about myocardial fibrosis. Our imaging data were not confirmed by histological approaches since this would have required biopsies, which was considered too invasive. Also, endomyocardial biopsy has a low diagnostic accuracy, which is due to the patchy nature of the myocardial involvement in GPA patients [36] . We did not include a control group of healthy subjects, precluding any firm conclusions about the higher frequency of abnormalities. Finally, the patients did not systematically undergo echocardiography and we did not measure 2D-strain or perform NT-proBNP and troponin assays.
Our study shows that CMRI is a sensitive technique for detecting heart involvement in GPA. The unique non-invasive information obtained with this technique may have important clinical implications for the early and accurate assessment of active cardiac lesions or cumulative damage in GPA patients. This technique could also yield powerful prognostic factors. Further longitudinal studies are required to determine whether CMRI abnormalities have a significant clinical impact on prognosis and treatment strategy.
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